Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues.

[1]  S. Paludan,et al.  Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. , 2006, The Journal of general virology.

[2]  C. Pert,et al.  Chemokine receptor 5 antagonist d-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease , 2005, Neuroscience.

[3]  C. Eckman,et al.  Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention , 2005 .

[4]  Xiang-Jiao Yang,et al.  Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription Factors , 2005, Molecular and Cellular Biology.

[5]  S. Gibbs,et al.  Increased CCL27–CCR10 expression in allergic contact dermatitis: implications for local skin memory , 2004, The Journal of pathology.

[6]  M. Bittner,et al.  Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome , 2004, Oncogene.

[7]  D. Holtzman,et al.  Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Mark P. Mattson,et al.  Infectious agents and age-related neurodegenerative disorders , 2003, Ageing Research Reviews.

[9]  B. Gesser,et al.  Expression of the T‐helper 2‐specific chemokine receptor CCR4 on CCR10‐positive lymphocytes in atopic dermatitis skin but not in psoriasis skin , 2003, The British journal of dermatology.

[10]  L. Marlow,et al.  Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme* , 2003, The Journal of Biological Chemistry.

[11]  M. Ball,et al.  Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.

[12]  B. Hyman,et al.  LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. , 2002, Brain research. Molecular brain research.

[13]  Pierre J Magistretti,et al.  Aquaporins in Brain: Distribution, Physiology, and Pathophysiology , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  H. Soto,et al.  CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.

[15]  James J. Campbell,et al.  CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin , 2001, The Journal of experimental medicine.

[16]  J M Lee,et al.  A gene expression profile of Alzheimer's disease. , 2001, DNA and cell biology.

[17]  C. Eckman,et al.  Degradation of the Alzheimer's Amyloid β Peptide by Endothelin-converting Enzyme* , 2001, The Journal of Biological Chemistry.

[18]  K Kosaka,et al.  Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. , 2001, Biochemical and biophysical research communications.

[19]  B. Hyman,et al.  Elevation of LDL Receptor‐Related Protein Levels via Ligand Interactions in Alzheimer Disease and In Vitro , 2001, Journal of neuropathology and experimental neurology.

[20]  A. Czernik,et al.  Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique , 2001, Neuroscience Letters.

[21]  V. Álvarez,et al.  Variation in the LRP-associated protein gene (LRPAP1) is associated with late-onset Alzheimer disease. , 2001, American journal of medical genetics.

[22]  V. Bond,et al.  Involvement of Protein Kinase C in HIV‐1 gpl20‐Induced Apoptosis in Primary Endothelium , 2000, Journal of acquired immune deficiency syndromes.

[23]  D. Strickland,et al.  LRP in Alzheimer's disease: friend or foe? , 2000, The Journal of clinical investigation.

[24]  R. Katzman.,et al.  Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. , 2000, The Journal of clinical investigation.

[25]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[26]  E. Butcher,et al.  Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. , 2000, Current opinion in immunology.

[27]  Weiqi Wang,et al.  Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1 , 2000, The Journal of Immunology.

[28]  R. Itzhaki,et al.  Herpes simplex virus type 1 and Alzheimer’s disease , 1999, Neurobiology of Aging.

[29]  J. Poirier,et al.  The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease , 1999, Neuroscience Letters.

[30]  Takayuki Itoh,et al.  Microglia Express CCR5, CXCR4, and CCR3, but of These, CCR5 Is the Principal Coreceptor for Human Immunodeficiency Virus Type 1 Dementia Isolates , 1999, Journal of Virology.

[31]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[32]  J. Woo,et al.  Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese , 1998, Neuroscience Letters.

[33]  H. Braak,et al.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.

[34]  H. Braak,et al.  Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.

[35]  A. Haase,et al.  Human herpes virus infections and Alzheimer's disease , 1990, Neuropathology and applied neurobiology.

[36]  G. Bu,et al.  LRP and Alzheimer's Disease , 2005, Reviews in the neurosciences.

[37]  C. Eckman,et al.  Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. , 2005, Biochemical Society transactions.

[38]  P. Ghezzi,et al.  Positive and negative regulation of APP amyloidogenesis by sumoylation , 2003 .

[39]  B T Hyman,et al.  Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. , 1999, Journal of neurovirology.